Can you provide the average price target for HUMANIGEN INC stock?
6 analysts have analysed HGEN and the average price target is 0.15 USD. This implies a price increase of 323.82% is expected in the next year compared to the current price of 0.0361.
HUMANIGEN INC (HGEN) Forecast, Price Target & Analyst Ratings
NASDAQ:HGEN • US4448632038
Current stock price
0.0361 USD
-0.16 (-81.12%)
At close:
0.0358 USD
0 (-0.83%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HUMANIGEN INC (HGEN).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Aug 10, 2023
- Period
- Q2 / 2023
- EPS Estimate
- -$0.04
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
$0.15
Upside
+ 323.82%
From current price of $0.04 to mean target of $0.15, Based on 6 analyst forecasts
Low
$0.15
Median
$0.15
High
$0.16
Price Target Revisions
1 Month
-53.85%
3 Months
-53.85%
Price Target Summary
6 Wall Street analysts provided a forecast for the next 12 months for HGEN. The average price target is 0.15 USD. This implies a price increase of 323.82% is expected in the next year compared to the current price of 0.0361.
The average price target has been revised downward by 53.85% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
43.33%
HGEN was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about HGEN.
In the previous month the buy percentage consensus was at a similar level.
HGEN was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-04-03 | Credit Suisse | Reiterate | Underperform |
| 2023-01-11 | Cantor Fitzgerald | Reiterate | Neutral |
| 2022-07-13 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2022-07-13 | Roth Capital | Downgrade | Buy -> Neutral |
| 2022-07-13 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2021-09-10 | Jefferies | Downgrade | Buy -> Hold |
| 2021-09-09 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2021-09-09 | HC Wainwright & Co. | Maintains | Buy |
| 2021-08-13 | Credit Suisse | Maintains | Outperform |
| 2021-08-10 | Roth Capital | Maintains | Buy |
| 2021-06-11 | Credit Suisse | Initiate | Outperform |
| 2021-05-07 | Oppenheimer | Initiate | Outperform |
| 2021-04-12 | HC Wainwright & Co. | Reiterate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Aug 10, 2023
- Period
- Q2 / 2023
- EPS Estimate
- -$0.04
- Revenue Estimate
- Revenue Q2Q
- -100.00%
- EPS Q2Q
- 90.51%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
33.33%
Next Earnings Summary
HGEN is expected to report earnings on 8/10/2023. The consensus EPS estimate for the next earnings is -0.04 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates 2023 - 2030
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 310K | 3.595M 1,059.68% | 2.514M -30.07% | 204K -91.89% | -100.00% | 44.472M | 87.516M 96.79% | 97.41M 11.31% | 105.77M 8.58% | 114.75M 8.49% | 124.44M 8.44% | |
| EBITDA YoY % growth | N/A -985.41% | N/A -164.94% | N/A 69.96% | -30.6M 60.37% | -26.47M 13.50% | -17.639M 33.36% | -111.486M -532.05% | -121.992M -9.42% | -109.14M 10.54% | N/A | N/A | |
| EBIT YoY % growth | -88.2M -886.58% | -232.772M -163.91% | -68.304M 70.66% | -47.43M 30.56% | -25.679M 45.86% | -9.125M 64.46% | 23.256M 354.85% | 30.906M 32.89% | 37.128M 20.13% | 43.962M 18.41% | 51.408M 16.94% | |
| Operating Margin | -28,451.61% | -6,474.88% | -2,716.95% | -23,250.00% | N/A | -20.52% | 26.57% | 31.73% | 35.10% | 38.31% | 41.31% | |
| EPS YoY % growth | N/A | -4.10 -123.49% | -0.93 77.32% | -0.15 83.55% | -0.09 40.00% | 0.08 188.89% | 0.06 -25.00% | 0.07 16.67% | 0.09 28.57% | 0.11 22.22% | 0.12 9.09% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q2 / 23 | Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.04 90.51% | -0.04 82.26% | -0.03 -161.20% | -0.02 49.00% | -0.02 50.00% | -0.02 50.00% | -0.02 33.33% |
| Revenue Q2Q % growth | -100.00% | -100.00% | -100.00% | -100.00% | |||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -5.202M 82.28% | -5.406M 76.21% | -5.712M -232.93% | -5.1M -20.43% | -4.998M 3.92% | -4.896M 9.43% | -4.692M 17.86% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
27.81%
EPS Next 5 Year
15.74%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
165.44%
Revenue Next 5 Year
110.13%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
21.33%
EBIT Next 5 Year
-8.13%
HUMANIGEN INC / HGEN Forecast FAQ
When does HUMANIGEN INC (HGEN) report earnings?
HUMANIGEN INC (HGEN) will report earnings on 2023-08-10.
What are the consensus estimates for HUMANIGEN INC (HGEN) next earnings?
The consensus EPS estimate for the next earnings of HUMANIGEN INC (HGEN) is -0.04 USD and the consensus revenue estimate is 0 USD.
What is the consensus rating for HUMANIGEN INC (HGEN) stock?
The consensus rating for HUMANIGEN INC (HGEN) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.